MedTrace Logo

Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy

NCT07075731 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-07-20

No results posted yet for this study

Summary

This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future

Conditions

  • Cancer Screening
  • Transgender
  • Gender Diverse Populations

Interventions

OTHER

No intervention

Observational study

Sponsors & Collaborators

Principal Investigators

  • Meredith Wise · University of Minnesota

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-30
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07075731 on ClinicalTrials.gov